Literature DB >> 10860197

Validity and reliability of the 6-minute walk test in a cardiac rehabilitation population.

D M Hamilton1, R G Haennel.   

Abstract

PURPOSE: Although the 6-minute walk test is commonly used to assess the functional status of patients with severe cardiopulmonary disease, few studies have tested its value in a cardiac rehabilitation (CR) population with milder disease status. The purpose of this study was to examine the validity and reliability of the 6-minute walk in a Phase II/III CR program.
METHODS: Ninety-four patients (61 men, 33 women) aged 63 +/- 10 years completed three 6-minute walks on nonconsecutive days. Patients also completed the Duke Activity Status Index (DASI) and the Short Form 36 Health Survey (SF-36). In addition, maximum metabolic equivalents (METs) from a symptom-limited graded exercise test were obtained from files.
RESULTS: The 6-minute walk was linearly related to maximum METs (r = 0.687, P < 0.001), supporting the validity of the test. Patients walked significantly farther in each 6-minute walk (F = 19.83, P < 0.001), and strong test-retest reliability was demonstrated (intraclass correlation = 0.97). Distance walked decreased with older age (F = 19.49, P < 0.001), with men walking farther than women (F = 7.19, P < 0.01). The 6-minute walk was moderately correlated with scores from the DASI (r = 0.502, P < 0.001), and the Physical Function subscale of the SF-36 (r = 0.624, P < 0.001).
CONCLUSIONS: The 6-minute walk is a valid and reliable method of assessing functional ability in a Phase II/III CR population. A learning effect of 6% was observed over the three walks; however, it is unknown if this learning effect will be retained over time. This test may be particularly valuable to smaller CR centers that want to document functional improvements but do not have access to conventional treadmill tests.

Entities:  

Mesh:

Year:  2000        PMID: 10860197     DOI: 10.1097/00008483-200005000-00003

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  53 in total

1.  Physical therapy management and patient outcomes following ICU-acquired weakness: a case series.

Authors:  Amy Nordon-Craft; Margaret Schenkman; Kyle Ridgeway; Alexander Benson; Marc Moss
Journal:  J Neurol Phys Ther       Date:  2011-09       Impact factor: 3.649

2.  Progression of symptoms and functioning among female cardiac patients with and without diabetes.

Authors:  Mary R Janevic; Nancy K Janz; Cathleen M Connell; Niko Kaciroti; Noreen M Clark
Journal:  J Womens Health (Larchmt)       Date:  2010-11-22       Impact factor: 2.681

3.  Effects of a 10-week inspiratory muscle training program on lower-extremity mobility in people with multiple sclerosis: a randomized controlled trial.

Authors:  Lucinda Pfalzer; Donna Fry
Journal:  Int J MS Care       Date:  2011

4.  Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test.

Authors:  J Matt McCrary; David Goldstein; David Wyld; Robert Henderson; Craig R Lewis; Susanna B Park
Journal:  J Cancer Surviv       Date:  2019-06-06       Impact factor: 4.442

5.  Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure.

Authors:  Rebecca A Gary; Sandra B Dunbar; Melinda K Higgins; Dominique L Musselman; Andrew L Smith
Journal:  J Psychosom Res       Date:  2010-03-12       Impact factor: 3.006

6.  High versus low training frequency in cardiac rehabilitation using a systems model of training.

Authors:  S Le Bris; B Ledermann; N Topin; P Messner-Pellenc; D Le Gallais
Journal:  Eur J Appl Physiol       Date:  2005-09-26       Impact factor: 3.078

7.  Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure.

Authors:  Kitty S Chan; Elizabeth R Pfoh; Linda Denehy; Doug Elliott; Anne E Holland; Victor D Dinglas; Dale M Needham
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

8.  Exercise self-regulation among older women participating in a heart disease-management intervention.

Authors:  Mary R Janevic; Nancy K Janz; Niko Kaciroti; Julia A Dodge; Steven J Keteyian; Lori Mosca; Noreen M Clark
Journal:  J Women Aging       Date:  2010

9.  The protective effects of a novel fitness-fatness index on all-cause mortality among adults with cardiovascular disease.

Authors:  Emily Frith; Paul D Loprinzi
Journal:  Clin Cardiol       Date:  2017-03-10       Impact factor: 2.882

10.  Early Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure After Acute Decompensation: A Case Series Analysis.

Authors:  Domenico Acanfora; Pietro Scicchitano; Chiara Acanfora; Roberto Maestri; Fernando Goglia; Raffaele Antonelli Incalzi; Alessandro Santo Bortone; Marco Matteo Ciccone; Massimo Uguccioni; Gerardo Casucci
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.